Татьянченко Владимир Константинович (RU),Красенков Юрий Викторович (RU),Фирсов Максим Сергеевич (RU),Богданов Валерий Леонидович (RU),Давыденко Андрей Викторович (RU)
申请号：
RU2015112990/14
公开号：
RU0002587972C1
申请日:
2015.04.08
申请国别(地区):
RU
年份:
2016
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention can be used for prevention of hypertrophic scars in treating phlegmons of soft tissues. That is ensured by daily histological examination of impression smear and laboratory examination type of acetylation. For acetyl activity more than 30 % and observing phase II wound process, a system of conservative therapy involves local application of Egallohit ointment for 5 days, and if phase III wound process is observed - phonophoresis of Contractubex gel for 5 days. For acetyl activity from 30 up to 20 % and observing phase II wound process system of conservative therapy involves local application of Egallohit ointment for 7 days, and if phase III wound process is observbed - phonophoresis of Contractubex gel for 7 days, and then electrophoresis of Caripazim 350 PE for 7 days. For acetyl activity of less than 20 % and observing phase II wound process system of conservative therapy involves introduction of Longidase in 1.0 ml intramuscularly 1 time in 3 days in amount of 10 injections, local application of Egallohit ointment for 10 days, and if phase III wound process is observed - phonophoresis of Contractubex gel for 10 days, then electrophoresis of Caripazim 350 PE for 10 days, laser therapy for 10 minutes for 5 days.EFFECT: reducing rate of formation of hypertrophic scars due to prevention of excessive scarring, elimination of inflammation and stimulating repair taking into account patients individual characteristics with respect to excess scarring.1 cl, 3 exИзобретение относится к медицине, а именно к гнойной хирургии, и может быть использовано для профилактики гипертрофических рубцов при лечении флегмон мягких тканей. Для этого проводят ежедневное гистологическое исследование мазка-отпечатка и лабораторное исследование типа ацетилирования. При ацетилярной активности более 30% и выявлении II фазы раневого процесса, комплекс консервативной терапии включает местное нанесение мази Эгаллохит в течение 5 дней, а при выявлении III фазы ра
